NCT03788369View on ClinicalTrials.gov

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

June 30, 2030

Study Completion Date

December 31, 2030

Conditions
Percutaneous Coronary RevascularizationCoronary StenosisCoronary Artery Disease ProgressionCoronary Artery Bypass Grafting
Interventions
PROCEDURE

Hybrid Coronary Revascularization

Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels.

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER